Contact Us
Search Icon

Suggested region and language based on your location

    Your current region and language

    people working in factory
    • Case Study
      Health & Safety

    Demonstrating Commitment to the Responsible Manufacture of Antibiotics

    GSK Worthing: First UK site with BSI Kitemark™ for Minimized Risk of AMR in antibiotics manufacturing.

    Testimonial

    “We believe that by taking these steps towards responsible antibiotic manufacturing, we can contribute to getting ahead of AMR.” 

    Lorraine Cancro Senior Director - Environmental Compliance and Remediation, GSK
    The Challenge

    Ensuring API emissions from manufacturing are kept below levels that negatively impact human health or the environment

    According to the World Health Organization, antimicrobial resistance (AMR) is one of the top 10 threats to global public health, and is expected to get worse unless action is taken.

    A driving cause of AMR is manufacturing waste from the production of antibiotics being released into the environment, for example through wastewater. While GSK had a formalized programme in place to review its internal and manufacturing supply chains to minimize risk of AMR, their achievement of BSI Kitemark certification takes this one step further, independently certifiying GSK’s responsible manufacturing practices and commitment to protecting public health and the environment.

    The Solution

    Demonstrating transparency, accountability and a commitment to addressing the global challenge of AMR

    GSK sought to update and enhance its existing AMR programme and documentation procedures in order to gain the internationally recognized BSI Kitemark for Minimized Risk of Antimicrobial Resistance.

    Achieving Kitemark certification involved evaluating the manufacturing processes of seven antibiotic products at the GSK Worthing site. On-site inspection of manufacturing operations was conducted by BSI auditors,including reviews of the wastewater treatment operations, storage areas, and interviews with key site team members. As part of its efforts to combat AMR and positively impact the health of people and the planet, GSK has committed to certification at all its antibiotic manufacturing sites around the world by 2026.

    The Benefits

    How BSI Kitemark certification at its Worthing manufacturing site is helping GSK to address AMR and achieve its environmental management goals:

    People discussing in the office
    • down arrow

      Assurance that the antibiotics manufacturing process meets the highest international standard.

    • home icon

      Demonstrates its commitment to addressing AMR and minimizing antimicrobial waste in the environment.

    • plus icon

      Ensures waste streams containing APIs and drug products are suitably controlled during manufacturing.

    • Tick icon

      Helps protect the efficacy of antibiotics in fighting diseases.

    • Icon description

      Validates compliance with the AMR Industry Alliance’s Antibiotic Manufacturing standard.

    • Icon description

      BSI Kitemark certification further assures healthcare procurers, investors, and customers.

    Commitment to AMR research

    GSK is playing a leading role in the fight against AMR. Key figures include:

    • 12

      R&D projects targeting pathogens deemed ‘critical’ or ‘urgent’ by WHO and US CDC.

    • 1st

      in more than 75 countries worldwide.

    • 1st

      in the Access to Medicine Foundation’s AMR Benchmark innovation category.

    • £45 million

      Pledged to the Fleming Initiative, to develop new AMR interventions.

    • 22

      Years of running the Survey of Antibiotic Resistance, a multinational surveillance programme.

    • 70

      Years of expertise in infectious disease R&D.

    People discussion
    Why BSI

    Working in partnership for a healthier world

    This Kitemark has been developed together with the AMR Industry Alliance (AMRIA), and others, to bring trust, evidence, and supply chain visibility.

    Achieving certification through the BSI Kitemark™ for Minimized Risk of AMR Certification addresses a WHO global health threat, assures stakeholders, and helps protect antibiotic efficacy for future generations.

    Contact Us

    Addressing antimicrobial resistance together

    Build trust and confidence with the BSI Kitemark™ for minimized risk of antimicrobial resistance.

    Get in touch